Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients

European Journal of Neurology

Volumn 21, Issue 3, 2014, Pages 519-524

  Martinez Martin P ^a   Rodriguez Blazquez C ^a   Forjaz, M J ^a   Alvarez Sanchez M ^b   Arakaki, T ^c   Bergareche Yarza, A ^d   Chade, A ^e   Garretto, N ^c   Gershanik, O ^e   Kurtis, M M ^f   Martinez Castrillo J C ^g   Mendoza Rodriguez A ^h   Moore, H P ⁱ   Rodriguez Violante M ^j   Singer, C ⁱ   Tilley, B C ^k   Huang, J ^k   Stebbins, G T ^l   Goetz, C G ^l  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d HOSPITAL DONOSTIA   (Spain)

^e FAVALORO UNIVERSITY   (Argentina)

^f HOSPITAL RUBER INTERNACIONAL   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h Hospital Complejo Asistencial de Segovia   (Spain)

ⁱ UNIVERSITY OF MIAMI   (United States)

^j NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^k UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

EQ 5D; Health related quality of life; MDS UPDRS; Parkinson's disease; PDQ 8; Rating scales

Indexed keywords

EQ-5D; HEALTH-RELATED QUALITY OF LIFE; MDS-UPDRS; PARKINSON'S DISEASE; PDQ-8; RATING SCALES;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84893840656     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12349     Document Type: Article

References (40)

1. Fahn S, Elton R, UPDRS program members. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-163.
2. Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22: 41-47.
3. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170.
4. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003; 18: 738-750.
5. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord 2012; 27: 79-83.
6. Antonini A, Abbruzzese G, Ferini-Strambi L, et al. Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. Neurol Sci 2013; 34: 683-687.
7. Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, et al. Expanded and independent validation of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol 2013; 260: 228-236.
8. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord 2008; 23: 653-659.
9. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-312.
10. Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008; 255: 1580-1587.
11. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008; 23: 1428-1434.
12. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008; 70: 2241-2247.
13. Post B, Muslimovic D, van Geloven N, Speelman JD, Schmand B, de Haan RJ. Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease. Mov Disord 2011; 26: 449-456.
14. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005; 20: 224-230.
15. Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, Burns A. Behavioural disorders, disability and quality of life in Parkinson's disease. Age Ageing 2011; 40: 614-621.
16. Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging 2006; 23: 693-721.
17. Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson's disease: a systematic review. Mov Disord 2007; 22: 1528-1537.
18. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011; 26: 399-406.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
20. Martínez-Martín P, Forjaz MJ, Cubo E, Frades B, De Pedro Cuesta J. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 2006; 21: 208-214.
21. Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, de Pedro J. The Clinical Impression of Severity Index for Parkinson's disease: international validation study. Mov Disord 2009; 24: 211-217.
22. Martinez Martin P, Forjaz MJ, Frades B, De Pedro-Cuesta J. La Rapid Assessment Disability Scale (RAD) en Enfermedad de Parkinson. Gac Sanit 2005; 19 (Suppl. 1): 68.
23. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007; 22: 1901-1911.
24. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009; 73: 1584-1591.
25. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997; 12: 805-814.
26. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
27. Martinez-Martin P, Jeukens-Visser M, Lyons KE, et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord 2011; 26: 2371-2380.
28. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-357.
29. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005; 76: 58-63.
30. Soh S-E, McGinley JL, Watts JJ, et al. Determinants of health-related quality of life in people with Parkinson's disease: a path analysis. Qual Life Res 2013; 22: 1543-1553.
31. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
32. Soh S-E, Morris ME, McGinley JL. Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011; 17: 1-9.
33. Storch A, Schneider CB, Wolz M, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 2013; 80: 800-809.
34. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000; 69: 584-589.
35. Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov Disord 2012; 27: 236-241.
36. Herlofson K, Larsen JP. The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003; 107: 1-6.
37. Benito-León J, Cubo E, Coronell C. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study. Mov Disord 2012; 27: 211-218.
38. Yamanishi T, Tachibana H, Oguru M, et al. Anxiety and depression in patients with Parkinson's disease. Int Med (Tokyo, Japan) 2013; 52: 539-545.
39. Fabbrini G, Latorre A, Suppa A, Bloise M, Frontoni M, Berardelli A. Fatigue in Parkinson's disease: motor or non-motor symptom? Parkinsonism Relat Disord 2013; 19: 148-152.
40. Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 2011; 17: 693-697.